SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 163 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $161,000 | -46.0% | 128,160 | -5.2% | 0.00% | -100.0% |
| Q3 2021 | $298,000 | -41.1% | 135,260 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $506,000 | +18.8% | 135,260 | +3.4% | 0.00% | 0.0% |
| Q1 2021 | $426,000 | -11.8% | 130,823 | -7.7% | 0.00% | 0.0% |
| Q4 2020 | $483,000 | -25.3% | 141,723 | -10.8% | 0.00% | 0.0% |
| Q3 2020 | $647,000 | +37.4% | 158,838 | +13.7% | 0.00% | 0.0% |
| Q2 2020 | $471,000 | +47.2% | 139,638 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $320,000 | -36.4% | 139,638 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $503,000 | -58.7% | 139,638 | -1.2% | 0.00% | -66.7% |
| Q2 2019 | $1,219,000 | -19.1% | 141,311 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $1,507,000 | +33.1% | 141,311 | +0.7% | 0.00% | +33.3% |
| Q4 2018 | $1,132,000 | -42.7% | 140,269 | +19.3% | 0.00% | -40.0% |
| Q3 2018 | $1,974,000 | -19.9% | 117,563 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $2,463,000 | +31.2% | 117,563 | +0.7% | 0.01% | +20.0% |
| Q1 2018 | $1,878,000 | -15.1% | 116,735 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $2,212,000 | +54.0% | 116,735 | +9.6% | 0.01% | +25.0% |
| Q3 2017 | $1,436,000 | +92.8% | 106,469 | +6.4% | 0.00% | +100.0% |
| Q2 2017 | $745,000 | +23.1% | 100,032 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $605,000 | +56.3% | 93,232 | +6.6% | 0.00% | +100.0% |
| Q4 2016 | $387,000 | -52.6% | 87,477 | -50.0% | 0.00% | 0.0% |
| Q3 2016 | $816,000 | +64.5% | 174,954 | +131.3% | 0.00% | 0.0% |
| Q2 2016 | $496,000 | +2510.5% | 75,633 | +2395.3% | 0.00% | – |
| Q1 2016 | $19,000 | +5.6% | 3,031 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | 0.0% | 3,031 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -14.3% | 3,031 | 0.0% | 0.00% | – |
| Q2 2015 | $21,000 | +16.7% | 3,031 | 0.0% | 0.00% | – |
| Q1 2015 | $18,000 | -14.3% | 3,031 | 0.0% | 0.00% | – |
| Q4 2014 | $21,000 | -16.0% | 3,031 | 0.0% | 0.00% | – |
| Q3 2014 | $25,000 | 0.0% | 3,031 | 0.0% | 0.00% | – |
| Q2 2014 | $25,000 | +4.2% | 3,031 | 0.0% | 0.00% | – |
| Q1 2014 | $24,000 | -11.1% | 3,031 | 0.0% | 0.00% | – |
| Q4 2013 | $27,000 | – | 3,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |